Evidence map›Paper›PMID 12529385›Full record

ArticleMolecular and cellular biology2003

Critical role for mouse Hus1 in an S-phase DNA damage cell cycle checkpoint.

Robert S Weiss, Philip Leder, Cyrus Vaziri

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 71 citations in OpenAlex.

  1. DNA Damage Responses, the Trump Card of Stem Cells in the Survival Game.Advances in experimental medicine and biology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Defective p53 engagement after the induction of DNA damage in cells deficient in topoisomerase 3beta.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Robert S WeissDepartment of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Philip Leder
Cyrus Vaziri
Cancer Research Center · USHoward Hughes Medical Institute · US

Funding

Tumor Cell Biology Training ProgramT32CA009361 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRAY, NATHANAEL SCHIANDER · 1985 to 2015
$8.9M
A Novel Carcinogen-Induced Cell Cycle CheckpointR01ES009558 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VAZIRI, CYRUS · 2002 to 2016
$4.8M
BIOLOGY OF THE OVARIAN FOLLICLE STEM CELLSF32CA009361 · NCI · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI MARGOLIS, JONATHAN S · 1992 to 1994
–
NCI NIH HHS CA 09361-20NCI NIH HHS F32 CA009361NCI NIH HHS T32 CA009361NIEHS NIH HHS R01 ES009558
6 · The paper itself

Abstract

Mouse Hus1 encodes an evolutionarily conserved DNA damage response protein. In this study we examined how targeted deletion of Hus1 affects cell cycle checkpoint responses to genotoxic stress. Unlike hus1(-) fission yeast (Schizosaccharomyces pombe) cells, which are defective for the G(2)/M DNA damage checkpoint, Hus1-null mouse cells did not inappropriately enter mitosis following genotoxin treatment. However, Hus1-deficient cells displayed a striking S-phase DNA damage checkpoint defect. Whereas wild-type cells transiently repressed DNA replication in response to benzo(a)pyrene dihydrodiol epoxide (BPDE), a genotoxin that causes bulky DNA adducts, Hus1-null cells maintained relatively high levels of DNA synthesis following treatment with this agent. However, when treated with DNA strand break-inducing agents such as ionizing radiation (IR), Hus1-deficient cells showed intact S-phase checkpoint responses. Conversely, checkpoint-mediated inhibition of DNA synthesis in response to BPDE did not require NBS1, a component of the IR-responsive S-phase checkpoint pathway. Taken together, these results demonstrate that Hus1 is required specifically for one of two separable mammalian checkpoint pathways that respond to distinct forms of genome damage during S phase.

Indexed as

DNA Damage7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAnimalsCell Cycle ProteinsCells, CulturedCheckpoint Kinase 1G2 PhaseGene TargetingMiceMice, KnockoutMitosisPhosphorylationProtein KinasesSchizosaccharomycesSchizosaccharomyces pombe ProteinsS Phase7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideCell Cycle ProteinsCheckpoint Kinase 1hus1 protein, S pombeProtein KinasesSchizosaccharomyces pombe Proteins

Identifiers

PMID12529385
PMCPMC140711
OpenAlexW2111893606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.